Gemina Laboratories Stock Fundamentals
| GLABF Stock | USD 0.55 0.01 1.79% |
Gemina Laboratories fundamentals help investors to digest information that contributes to Gemina Laboratories' financial success or failures. It also enables traders to predict the movement of Gemina OTC Stock. The fundamental analysis module provides a way to measure Gemina Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gemina Laboratories otc stock.
Gemina |
Gemina Laboratories OTC Stock Operating Margin Analysis
Gemina Laboratories' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Gemina Laboratories Operating Margin | 979.18 % |
Most of Gemina Laboratories' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Gemina Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Gemina Laboratories has an Operating Margin of 979%. This is 2891.28% lower than that of the Healthcare sector and notably lower than that of the Biotechnology industry. The operating margin for all United States stocks is notably lower than that of the firm.
Gemina Laboratories Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Gemina Laboratories's current stock value. Our valuation model uses many indicators to compare Gemina Laboratories value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Gemina Laboratories competition to find correlations between indicators driving Gemina Laboratories's intrinsic value. More Info.Gemina Laboratories is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Gemina Laboratories' earnings, one of the primary drivers of an investment's value.Gemina Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Gemina Laboratories' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Gemina Laboratories could also be used in its relative valuation, which is a method of valuing Gemina Laboratories by comparing valuation metrics of similar companies.Gemina Laboratories is currently under evaluation in operating margin category among its peers.
Gemina Fundamentals
| Return On Equity | -3.47 | |||
| Return On Asset | -1.48 | |||
| Operating Margin | 979.18 % | |||
| Current Valuation | 17.22 M | |||
| Shares Outstanding | 64.1 M | |||
| Shares Owned By Insiders | 56.28 % | |||
| Price To Book | 9.70 X | |||
| Price To Sales | 5,790 X | |||
| EBITDA | (4.69 M) | |||
| Net Income | (4.73 M) | |||
| Cash And Equivalents | 2.95 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 12.47 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 2.50 X | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (3.87 M) | |||
| Earnings Per Share | (0.08) X | |||
| Market Capitalization | 33.65 M | |||
| Total Asset | 1.42 M | |||
| Net Asset | 1.42 M |
About Gemina Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Gemina Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gemina Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gemina Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. Gemina Laboratories operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Gemina OTC Stock
Gemina Laboratories financial ratios help investors to determine whether Gemina OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gemina with respect to the benefits of owning Gemina Laboratories security.